全文获取类型
收费全文 | 2370081篇 |
免费 | 198175篇 |
国内免费 | 4202篇 |
专业分类
耳鼻咽喉 | 34259篇 |
儿科学 | 72728篇 |
妇产科学 | 62922篇 |
基础医学 | 334760篇 |
口腔科学 | 67515篇 |
临床医学 | 215346篇 |
内科学 | 468089篇 |
皮肤病学 | 47924篇 |
神经病学 | 200694篇 |
特种医学 | 95944篇 |
外国民族医学 | 886篇 |
外科学 | 360308篇 |
综合类 | 56204篇 |
现状与发展 | 1篇 |
一般理论 | 977篇 |
预防医学 | 190368篇 |
眼科学 | 55433篇 |
药学 | 177485篇 |
4篇 | |
中国医学 | 4365篇 |
肿瘤学 | 126246篇 |
出版年
2018年 | 24201篇 |
2016年 | 20571篇 |
2015年 | 23278篇 |
2014年 | 33532篇 |
2013年 | 50825篇 |
2012年 | 68732篇 |
2011年 | 72271篇 |
2010年 | 42469篇 |
2009年 | 40860篇 |
2008年 | 68755篇 |
2007年 | 73092篇 |
2006年 | 73993篇 |
2005年 | 72032篇 |
2004年 | 69331篇 |
2003年 | 67010篇 |
2002年 | 66257篇 |
2001年 | 112449篇 |
2000年 | 116524篇 |
1999年 | 98333篇 |
1998年 | 27858篇 |
1997年 | 25521篇 |
1996年 | 25447篇 |
1995年 | 24609篇 |
1994年 | 23159篇 |
1993年 | 21552篇 |
1992年 | 79386篇 |
1991年 | 76393篇 |
1990年 | 73575篇 |
1989年 | 70841篇 |
1988年 | 65846篇 |
1987年 | 64800篇 |
1986年 | 61334篇 |
1985年 | 58399篇 |
1984年 | 44222篇 |
1983年 | 37657篇 |
1982年 | 22886篇 |
1981年 | 20332篇 |
1980年 | 19034篇 |
1979年 | 41299篇 |
1978年 | 28985篇 |
1977年 | 24346篇 |
1976年 | 22832篇 |
1975年 | 23964篇 |
1974年 | 29638篇 |
1973年 | 28042篇 |
1972年 | 26226篇 |
1971年 | 24151篇 |
1970年 | 22752篇 |
1969年 | 21087篇 |
1968年 | 19135篇 |
排序方式: 共有10000条查询结果,搜索用时 844 毫秒
241.
242.
243.
244.
L. Misery E. Weisshaar E. Brenaut A.W.M. Evers F. Huet S. Ständer A. Reich E. Berardesca E. Serra-Baldrich J. Wallengren D. Linder J.W. Fluhr J.C. Szepietowski H. Maibach for the Special Interest Group on sensitive skin of the International Forum for the Study of Itch 《Journal of the European Academy of Dermatology and Venereology》2020,34(2):222-229
The special interest group on sensitive skin of the International Forum for the Study of Itch previously defined sensitive skin as a syndrome defined by the occurrence of unpleasant sensations (stinging, burning, pain, pruritus and tingling sensations) in response to stimuli that normally should not provoke such sensations. This additional paper focuses on the pathophysiology and the management of sensitive skin. Sensitive skin is not an immunological disorder but is related to alterations of the skin nervous system. Skin barrier abnormalities are frequently associated, but there is no cause and direct relationship. Further studies are needed to better understand the pathophysiology of sensitive skin – as well as the inducing factors. Avoidance of possible triggering factors and the use of well-tolerated cosmetics, especially those containing inhibitors of unpleasant sensations, might be suggested for patients with sensitive skin. The role of psychosocial factors, such as stress or negative expectations, might be relevant for subgroups of patients. To date, there is no clinical trial supporting the use of topical or systemic drugs in sensitive skin. The published data are not sufficient to reach a consensus on sensitive skin management. In general, patients with sensitive skin require a personalized approach, taking into account various biomedical, neural and psychosocial factors affecting sensitive skin. 相似文献
245.
Jennifer C. Sasaki Ashley Allemang Steven M. Bryce Laura Custer Kerry L. Dearfield Yasmin Dietz Azeddine Elhajouji Patricia A. Escobar Albert J. Fornace Jr Roland Froetschl Sheila Galloway Ulrike Hemmann Giel Hendriks Heng-Hong Li Mirjam Luijten Gladys Ouedraogo Lauren Peel Stefan Pfuhler Daniel J. Roberts Véronique Thybaud Jan van Benthem Carole L. Yauk Maik Schuler 《Environmental and molecular mutagenesis》2020,61(1):114-134
In May 2017, the Health and Environmental Sciences Institute's Genetic Toxicology Technical Committee hosted a workshop to discuss whether mode of action (MOA) investigation is enhanced through the application of the adverse outcome pathway (AOP) framework. As AOPs are a relatively new approach in genetic toxicology, this report describes how AOPs could be harnessed to advance MOA analysis of genotoxicity pathways using five example case studies. Each of these genetic toxicology AOPs proposed for further development includes the relevant molecular initiating events, key events, and adverse outcomes (AOs), identification and/or further development of the appropriate assays to link an agent to these events, and discussion regarding the biological plausibility of the proposed AOP. A key difference between these proposed genetic toxicology AOPs versus traditional AOPs is that the AO is a genetic toxicology endpoint of potential significance in risk characterization, in contrast to an adverse state of an organism or a population. The first two detailed case studies describe provisional AOPs for aurora kinase inhibition and tubulin binding, leading to the common AO of aneuploidy. The remaining three case studies highlight provisional AOPs that lead to chromosome breakage or mutation via indirect DNA interaction (inhibition of topoisomerase II, production of cellular reactive oxygen species, and inhibition of DNA synthesis). These case studies serve as starting points for genotoxicity AOPs that could ultimately be published and utilized by the broader toxicology community and illustrate the practical considerations and evidence required to formalize such AOPs so that they may be applied to genetic toxicity evaluation schemes. Environ. Mol. Mutagen. 61:114–134, 2020. © 2019 Wiley Periodicals, Inc. 相似文献
246.
247.
248.
249.
Parallel enzyme‐linked immunosorbent assay screening for human immunodeficiency virus among blood donors in five Chinese blood centres: a retrospective analysis
下载免费PDF全文
![点击此处可从《Transfusion medicine (Oxford, England)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
250.
Amos Adler Na'ama Sturlesi Noga Fallach Deniz Zilberman-Barzilai Omar Hussein Shlomo E. Blum Eyal Klement Mitchell J. Schwaber Yehuda Carmeli 《Journal of clinical microbiology》2015,53(11):3515-3521
Our objectives were to study the prevalence, risk factors for carriage, and transmission dynamics of extended-spectrum-β-lactamase (ESBL)-producing Enterobacteriaceae (ESBLPE) in a national survey of cattle. This was a point prevalence study conducted from July to October 2013 in Israel. Stool samples were collected from 1,226 cows in 123 sections on 40 farms of all production types. ESBLPE were identified in 291 samples (23.7%): 287 contained Escherichia coli and 4 contained Klebsiella pneumoniae. The number of ESBLPE-positive cows was the highest in quarantine stations and on fattening farms and was the lowest on pasture farms (P = 0.03). The number of ESBLPE-positive cows was the lowest in sections containing adult cows (age, >25 months) and highest in sections containing calves (age, <4 months) (P < 0.001). Infrastructure variables that were significant risk factors for ESBLPE carriage included crowding, a lack of manure cleaning, and a lack of a cooling (P < 0.001 for each), all of which were more common in sections containing calves. Antimicrobial prophylaxis was given almost exclusively to calves and was associated with a high number of ESBLPE carriers (P < 0.001). The 287 E. coli isolates were typed into 106 repetitive extragenic palindromic (REP)-PCR types and mostly harbored blaCTX-M-1 or blaCTX-M-9 group genes. The isolates on the six farms with ≥15 isolates of ESBLPE were of 4 to 7 different REP-PCR types, with one dominant type being harbored by about half of the isolates. Fourteen types were identified on more than one farm, with only six of the farms being adjacent to each other. The prevalence of ESBLPE carriage is high in calves in cowsheds where the use of antimicrobial prophylaxis is common. ESBLPE disseminate within cowsheds mainly by clonal spread, with limited intercowshed transmission occurring. 相似文献